SHH and medulloblastoma: Based on findings from clinical-based studies, male-to-female ratios differ between molecular subgroups, with WNT and SHH groups showing approximately equal male and female distributions, but Group 3 and Group 4 medulloblastoma comprised with about twice as many males (11, 35).